Marie-francoise Ritz

Basel, BS 4031, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Quantitative Proteomic Analysis Reveals Different Functional Subtypes among IDH-Wildtype Glioblastoma.

Quantitative Proteomic Analysis Reveals Different Functional Subtypes among IDH-Wildtype Glioblastoma.

Journal: Journal of proteome research
Published: June 16, 2025

Stochastic Nanoscale Biophysical Cues as a Basis for the Induction of Glioblastoma-Like Transcriptional Programs in Astrocytes.

Stochastic Nanoscale Biophysical Cues as a Basis for the Induction of Glioblastoma-Like Transcriptional Programs in Astrocytes.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 25, 2025

Multidimensional analysis of matched primary and recurrent glioblastoma identifies contributors to tumor recurrence influencing time to relapse.

Multidimensional analysis of matched primary and recurrent glioblastoma identifies contributors to tumor recurrence influencing time to relapse.

Journal: Journal of neuropathology and experimental neurology
Published: October 18, 2024

FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma.

FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma.

Journal: Nature communications
Published: August 26, 2024

Leveraging multi-omics data to infer regulators of mRNA 3' end processing in glioblastoma.

Leveraging multi-omics data to infer regulators of mRNA 3' end processing in glioblastoma.

Journal: Frontiers in molecular biosciences
Published: December 31, 2023

Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation.

Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation.

Journal: eLife
Published: December 21, 2023

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker.

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker.

Journal: Nature communications
Published: October 25, 2023

Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.

Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.

Journal: Science translational medicine
Published: July 19, 2023

Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery.

Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery.

Journal: Science advances
Published: July 01, 2022

Microglia-Centered Combinatorial Strategies Against Glioblastoma.

Microglia-Centered Combinatorial Strategies Against Glioblastoma.

Journal: Frontiers in immunology
Published: June 12, 2020

Combined Transcriptomic and Proteomic Analyses of Cerebral Frontal Lobe Tissue Identified RNA Metabolism Dysregulation as One Potential Pathogenic Mechanism in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL).

Combined Transcriptomic and Proteomic Analyses of Cerebral Frontal Lobe Tissue Identified RNA Metabolism Dysregulation as One Potential Pathogenic Mechanism in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL).

Journal: Current neurovascular research
Published: October 01, 2019

Quantitative proteomics reveals reduction of endocytic machinery components in gliomas.

Quantitative proteomics reveals reduction of endocytic machinery components in gliomas.

Journal: EBioMedicine
Published: April 15, 2019
Showing 1-12 of 26

Last Updated: 09/26/2026